Confirmed Attendees Include:
AbbVie, Inc.
Adaptimmune, LLC
Advaxis, Inc.
Aethlon Medical, Inc.
Alpha Bronze
Altius Strategy Consulting
Amorchem
Apogenix AG
Aquilo Capital Management
Astellas Innovation Management LLC
Astellas US LLC
Aurgalys
Baxalta, Inc.
Bellicum Pharmaceuticals, Inc.
BerGenBio AS
Biosceptre
Biotech Alliances International, Inc.
Biothera
BliNK Biomedical SAS
Bloomberg News
Bristol-Myers Squibb
BTIG, LLC
Calamos Investments
Cancer Research Institute
Cantor Fitzgerald
Cell Design Labs
Chardan Capital Markets, LLC
Cleveland Clinic
Colorado Institute For Drug, Device & Diagnostic Development
Cowen and Company
Credit Suisse Securities (USA) LLC
Curis, Inc.
Daiichi Sankyo
Dana-Farber Cancer Institute
Dawson James Securities, Inc.
Deca Ventures
Defined Health
Easton Capital Investment Group
EcoR1 Capital, LLC
Edison Group
EMD Serono
Enso Ventures
Etubics Corporation
ex scientia Ltd.
F. Hoffmann-La Roche Ltd.
F1BioVentures
Fate Therapeutics, Inc.
FBR & Co.
FreeMind Group
F-star Biotechnology Ltd.
Galena Biopharma, Inc.
GC Finance
GlaxoSmithKline
GreenPeptide Co., Ltd.
H.C. Wainwright & Co., LLC
Healthy Assets
Immune Pharmaceuticals, Inc.
Immunicum
Immunova, LLC
J&J Innovation Centre-Boston
Jefferies, LLC
JP Morgan
Juno Therapeutics
JW Pharmaceutical Corporation
Katan Family Office
Kite Pharma
Laidlaw & Company
Loncar Investment, LLC
LOXO Oncology, Inc.
MaxCyte, Inc.
MD Anderson Cancer Center
Mediqventures
MedPro Investors, LLC
Melanoma Research Alliance
Memgen LLC
Merchant Liquidity Fund, LP
Merrimack Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
Modulate Therapeutics, Inc.
Moffitt Cancer Center
MPM Capital
MSD Research Laboratories
Nanobiotix
New Enterprise Associates
New Leaf Venture Partners
New Science Global Healthcare Fund
Nextech Invest Ltd.
Noble Life Science Partners
Noble Life Science Partners
Novartis
OncoSec Medical, Inc.
Oppenheimer & Co., Inc.
Organovo Holdings, Inc.
OSE Pharma
Oslo Life Science Advisors
Oxford Bioscience Partners
Pfenex, Inc.
Quadrivio Capital SGR S.p.A.
QVT Financial LP
Sante Ventures
SMR Consulting GmbH
Stifel Financial Corp.
SugarCone Biotech, LLC
SunTrust Robinson Humphrey
Takeda Pharmaceuticals
TESARO
The Leukemia & Lymphoma Society
The University of Texas MD Anderson Cancer Center
Torreya EM
Tracon Pharmaceuticals, Inc
TVM Capital
UbiVac
Versant Ventures
Vertex Healthcare Ventures
VI Partners AG
X-Chem, Inc.
Yorkville Advisors, LLC
ZIOPHARM Oncology, Inc.
AbbVie, Inc.
Adaptimmune, LLC
Advaxis, Inc.
Aethlon Medical, Inc.
Alpha Bronze
Altius Strategy Consulting
Amorchem
Apogenix AG
Aquilo Capital Management
Astellas Innovation Management LLC
Astellas US LLC
Aurgalys
Baxalta, Inc.
Bellicum Pharmaceuticals, Inc.
BerGenBio AS
Biosceptre
Biotech Alliances International, Inc.
Biothera
BliNK Biomedical SAS
Bloomberg News
Bristol-Myers Squibb
BTIG, LLC
Calamos Investments
Cancer Research Institute
Cantor Fitzgerald
Cell Design Labs
Chardan Capital Markets, LLC
Cleveland Clinic
Colorado Institute For Drug, Device & Diagnostic Development
Cowen and Company
Credit Suisse Securities (USA) LLC
Curis, Inc.
Daiichi Sankyo
Dana-Farber Cancer Institute
Dawson James Securities, Inc.
Deca Ventures
Defined Health
Easton Capital Investment Group
EcoR1 Capital, LLC
Edison Group
EMD Serono
Enso Ventures
Etubics Corporation
ex scientia Ltd.
F. Hoffmann-La Roche Ltd.
F1BioVentures
Fate Therapeutics, Inc.
FBR & Co.
FreeMind Group
F-star Biotechnology Ltd.
Galena Biopharma, Inc.
GC Finance
GlaxoSmithKline
GreenPeptide Co., Ltd.
H.C. Wainwright & Co., LLC
Healthy Assets
Immune Pharmaceuticals, Inc.
Immunicum
Immunova, LLC
J&J Innovation Centre-Boston
Jefferies, LLC
JP Morgan
Juno Therapeutics
JW Pharmaceutical Corporation
Katan Family Office
Kite Pharma
Laidlaw & Company
Loncar Investment, LLC
LOXO Oncology, Inc.
MaxCyte, Inc.
MD Anderson Cancer Center
Mediqventures
MedPro Investors, LLC
Melanoma Research Alliance
Memgen LLC
Merchant Liquidity Fund, LP
Merrimack Pharmaceuticals, Inc.
Mirna Therapeutics, Inc.
Modulate Therapeutics, Inc.
Moffitt Cancer Center
MPM Capital
MSD Research Laboratories
Nanobiotix
New Enterprise Associates
New Leaf Venture Partners
New Science Global Healthcare Fund
Nextech Invest Ltd.
Noble Life Science Partners
Noble Life Science Partners
Novartis
OncoSec Medical, Inc.
Oppenheimer & Co., Inc.
Organovo Holdings, Inc.
OSE Pharma
Oslo Life Science Advisors
Oxford Bioscience Partners
Pfenex, Inc.
Quadrivio Capital SGR S.p.A.
QVT Financial LP
Sante Ventures
SMR Consulting GmbH
Stifel Financial Corp.
SugarCone Biotech, LLC
SunTrust Robinson Humphrey
Takeda Pharmaceuticals
TESARO
The Leukemia & Lymphoma Society
The University of Texas MD Anderson Cancer Center
Torreya EM
Tracon Pharmaceuticals, Inc
TVM Capital
UbiVac
Versant Ventures
Vertex Healthcare Ventures
VI Partners AG
X-Chem, Inc.
Yorkville Advisors, LLC
ZIOPHARM Oncology, Inc.